(Q38177740)

30 August 2017

title

Managing Cushing's disease: the state of the art. (English)

1 reference

30 August 2017

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24415169%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Diego Ferone

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24415169%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

1

Annamaria Colao

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24415169%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Felipe Casanueva Freijo

series ordinal

4

object named as

Felipe F Casanueva

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24415169%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

publication date

11 January 2014

1 reference

30 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24415169%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24415169%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24415169%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

9-20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24415169%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Morbidity and mortality in Cushing's disease: an epidemiological approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Approach to the patient with possible Cushing's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Epidemiology of Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Diagnosis and treatment of pituitary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Transsphenoidal surgery for Cushing's disease: a review of success rates, remission predictors, management of failed surgery, and Nelson's Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Differential diagnosis of Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Management of Cushing's disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

An approach to the management of patients with residual Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Psychosomatic aspects of Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

The efficacy of linear accelerator radiosurgery in the management of patients with Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Partial visual recovery from radiation-induced optic neuropathy after hyperbaric oxygen therapy in a patient with Cushing disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Pharmacological management of Cushing's syndrome: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Genetics of Cushing's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Quality of life in patients with pituitary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Quality of life in patients with Cushing's disease: a modern approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Cushing's syndrome complicated by multiple opportunistic infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Nephrolithiasis in Cushing's disease: prevalence, etiopathogenesis, and modification after disease cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Skeletal diseases in Cushing's syndrome: osteoporosis versus arthropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

The burden of Cushing's disease: clinical and health-related quality of life aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Medical management of pituitary adenomas: the special case of management of the pregnant woman

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

The metabolic syndrome and cardiovascular risk in Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Cardiovascular Disease in Cushing’s Syndrome: Heart versus Vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Coronary microvascular function in patients with Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Metabolic Syndrome in Cushing’s Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Multisystem morbidity and mortality in Cushing's syndrome: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Diagnosis and complications of Cushing's syndrome: a consensus statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Mortality in Cushing's syndrome: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Clinical consequences of Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Cushing's syndrome: aftermath of the cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Spine abnormalities and damage in patients cured from Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Cushing's syndrome: a structured short- and long-term management plan for patients in remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Pediatric Cushing's syndrome: clinical features, diagnosis, and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Cushing's syndrome: why is diagnosis so difficult?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Unusual causes of Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Cushing's syndrome of nonpituitary causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Adrenal function in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Hypercortisolism caused by ritonavir associated inhibition of CYP 3A4 under inhalative glucocorticoid therapy. 2 case reports and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Topical corticosteroid-induced adrenocortical insufficiency: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Cushing's syndrome induced by misuse of moderate- to high-potency topical corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Exogenous Cushing's syndrome due to topical corticosteroid application: case report and review literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Accuracy of diagnostic tests for Cushing's syndrome: a systematic review and metaanalyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Update on late-night salivary cortisol for the diagnosis of Cushing's syndrome: methodological considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Demographic Factors and the Presence of Comorbidities do not Promote Early Detection of Cushing's Disease and Acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Endoscopic transsphenoidal pituitary surgery: evidence of an operative learning curve.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Approach to the Cushing's disease patient with persistent/recurrent hypercortisolism after pituitary surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Prospective evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Radiation therapy for Cushing's disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Repeat transsphenoidal surgery for Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Medical treatment of Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Pasireotide (SOM230): development, mechanism of action and potential applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Detection of synthetic glucocorticoids by liquid chromatography-tandem mass spectrometry in patients being investigated for Cushing's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Improved liquid chromatography-tandem mass spectrometry method in clinical utility for the diagnosis of Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Cushing's syndrome: diagnosis and surveillance using salivary cortisol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Dopamine receptor expression and function in corticotroph pituitary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

The medical treatment of Cushing's disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Cabergoline monotherapy in the long-term treatment of Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Role of dopamine receptors in normal and tumoral pituitary corticotropic cells and adrenal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Somatostatin-dopamine chimeras: a novel approach to treatment of neuroendocrine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Potential role for retinoic acid in patients with Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Medical Treatment of Cushing’s Syndrome: Glucocorticoid Receptor Antagonists and Mifepristone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

The use of the glucocorticoid receptor antagonist mifepristone in Cushing's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Mifepristone: is there a place in the treatment of Cushing's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0129-2

Outcomes of therapy for Cushing's disease due to adrenocorticotropin-secreting pituitary macroadenomas

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Cushing's syndrome and bone mineral density: lowest Z scores in young patients

1 reference

12 December 2020

New treatment guidelines on Cushing's disease

1 reference

12 December 2020

Pitfalls in the diagnosis of Cushing's syndrome

1 reference

12 December 2020

Corticotroph tumor progression after adrenalectomy in Cushing's Disease: A reappraisal of Nelson's Syndrome

1 reference

12 December 2020

The role of the clinical laboratory in the diagnosis of Cushing syndrome

1 reference

12 December 2020

1 reference

12 December 2020

CT and MR imaging of the adrenal glands in cortisol-secreting tumors.

1 reference

12 December 2020

Treatment Options in Cushing's Disease

1 reference

12 December 2020

The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states

1 reference

12 December 2020

Nodular pulmonary histoplasmosis in Cushing's disease: a case report and literature review.

1 reference

12 December 2020

ACTH-independent macronodular adrenal hyperplasia

1 reference

12 December 2020

MRI assessment of lean and adipose tissue distribution in female patients with Cushing's disease

1 reference

12 December 2020

Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results

1 reference

12 December 2020

Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years

1 reference

12 December 2020

A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease

1 reference

12 December 2020

A novel tool in the diagnosis and follow-up of (cyclic) Cushing's syndrome: measurement of long-term cortisol in scalp hair

1 reference

12 December 2020

Assessment of adrenal glucocorticoid function. Which tests are appropriate for screening?

1 reference

12 December 2020

Bariatric surgery for obesity and hidden Cushing syndrome

1 reference

12 December 2020

Bromocriptine suppresses ACTH secretion from human pituitary tumour cells in culture by a dopaminergic mechanism

1 reference

12 December 2020

Reproducibility and performance of one or two samples of salivary cortisol in the diagnosis of Cushing's syndrome using an automated immunoassay system

1 reference

12 December 2020

Incidence and Late Prognosis of Cushing’s Syndrome: A Population-Based Study1

1 reference

12 December 2020

Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure.

1 reference

12 December 2020

The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline: commentary from a European perspective

1 reference

12 December 2020

Cushing's syndrome: adrenalectomy and long-term results

1 reference

12 December 2020

Medical treatment of Cushing's disease: Overview and recent findings

1 reference

12 December 2020

Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas

1 reference

12 December 2020

Effect of injectable bromocriptine in patients with Cushing's disease

1 reference

12 December 2020

Gamma knife radiosurgery is a successful adjunctive treatment in Cushing's disease

1 reference

12 December 2020

Risk factors and long-term outcome in pituitary-dependent Cushing's disease

1 reference

12 December 2020

Concordance of the late night salivary cortisol in patients with Cushing's syndrome and elevated urine-free cortisol

1 reference

12 December 2020

Recent challenges in the diagnosis of Cushing's syndrome

1 reference

12 December 2020

Single-center experience with pediatric Cushing's disease

1 reference

12 December 2020

Principles and clinical applications of liquid chromatography - tandem mass spectrometry for the determination of adrenal and gonadal steroid hormones

1 reference

12 December 2020

Dynamic tests in the diagnosis and differential diagnosis of Cushing's syndrome

1 reference

12 December 2020

Salivary cortisol as a diagnostic tool for Cushing's syndrome and adrenal insufficiency: improved screening by an automatic immunoassay

1 reference

12 December 2020

Incidence and late prognosis of cushing's syndrome: a population-based study

1 reference

12 December 2020